Compare Danaher Corporation (DHR) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Palantir Technologies Inc — how do they compare? Danaher Corporation trades at $207.45 (market cap $145.83B), while Palantir Technologies Inc trades at $170.98 (market cap $420.39B). The key difference: Palantir Technologies Inc is far larger — about 2.9× Danaher Corporation's market cap, and Danaher Corporation pays a 0.77% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals.
| DHR | PLTR | |
|---|---|---|
Market Cap | $145.83B | $420.39B |
Sector | Health | Technology |
52-Week High | $242.05 | $207.18 |
52-Week Low | $161.91 | $107.27 |
Enterprise Value | $168.04B | $411.19B |
Dividend Yield | 0.77% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
PLTR trades at $171.42, down 2.16% on the day, with a bullish technical trend supported by moving averages but overbought RSI readings. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.41 actual versus $0.3446 expected, and revenue growth accelerated to $4.48 billion in 2025. Analyst consensus is bullish with a $213.44 price target, though high valuation ratios like a P/E of 149.52 pose concerns.
Outlook remains positive due to robust earnings growth and AI-driven demand, but risks include elevated valuations, insider selling, and bearish sentiment from notable investors like Michael Burry. The stock offers upside to consensus targets but requires monitoring for sustainability of profit margins and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
